Features & Benefits
- Broad Coverage:
Utilizes more than 200 antibodies to develop 3-D conformational fingerprint.
- Intelligent Database:
Data analysis is supported by extensive databank containing 150+ innovator and biosimilar fingerprints.
- Artificial Intelligence Driven Data Analysis
- Glycan Profiling
- Predictive of Functional Activities:
- Target binding
- ADCC and CDC activity
- Fc Receptor binding
Intelli.b – Biosimilar Fingerprinting Technology
Somru BioScience has developed Intelli.b™ – a platform for the comparability testing of biosimilars at a molecular level that meets the intent of the FDA guidance for fingerprint-like analysis. The Intelli.b™ platform is an integrated, multi-parameter approach that is extremely sensitive in identifying analytical differences (i.e. fingerprint-like analysis).
Application of Intelli.b
Harness power of laboratory automation to boost your drug development studies.
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Recommendations on ELISpot assay
Gene therapy, cell therapy and vaccine research have led to..
Read More ...Webinar Challenges & Solutions:
Now Streaming On-Demand The webinar began with an introduction to..
Read More ...Solution
Quality & Speed. Delivered Immunogenicity Learn More Biosimilar Development Learn..
Read More ...Privacy Policy
Privacy Policy At Somru BioScience Inc., we are committed to..
Read More ...